Pharma Deko Plc (NGX:PHARMDEKO)

Market Cap	396.98M
Revenue (ttm)	469.58M
Net Income (ttm)	-296.19M
Shares Out	216.93M
EPS (ttm)	-1.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	1.830
Day's Range	n/a
52-Week Range	1.830 - 1.830
Beta	-0.00
RSI	41.10
Earnings Date	Feb 9, 2026

About Pharma Deko

Pharma Deko Plc engages in manufacturing, packaging, and marketing pharmaceutical and consumer products in Nigeria. It operates through three segments: Pharma, Consumer, and Contract. The company offers cough and vitamins products under the Parkalin Pediatrics, Parkalin Chesty, and Parkalin with Codeine brands, as well as drops and syrups under the Vitacee and Pharmadec brands; Revitone blood tonic, Salins Liniment and Antasil tablets, Amoquin tablets, and Garlic tablets; prescription drugs, including Omepraz Capsules, Sparxin, Pidiclox dry pow...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 50
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: PHARMDEKO

Financial Performance

In 2022, Pharma Deko's revenue was 469.58 million, a decrease of -6.74% compared to the previous year's 503.55 million. Losses were -296.19 million, 324.4% more than in 2021.